Frequently Asked
Questions

Burrard Intelligence is our premium regulatory intelligence subscription designed for pharmaceutical companies, regulatory affairs teams, and consultants. Subscribers get unlimited CTD/eCTD template requests with 48-hour guaranteed delivery, monthly regulatory landscape reports, AI-powered formulation and stability insights, and priority access to our expert advisory team.

It's the fastest way to accelerate your regulatory submissions — every template is prepared by our experienced pharmaceutical scientists and regulatory specialists.

We offer three tiers: Intelligence Starter ($199/mo) for individual consultants with 5 CTD templates per month, Intelligence Pro ($499/mo) for regulatory teams with unlimited templates and full advisory access, and Intelligence Enterprise (custom pricing) for large organizations needing multi-seat licenses, dedicated account management, and custom integrations.

Each template is a market-ready regulatory dossier section prepared by our team. It includes Module 3 Quality documentation (drug substance and drug product), analytical method summaries, stability data overviews, manufacturing process descriptions, and specifications — all formatted to ICH CTD/eCTD standards and ready for your specific market submission.

Pro and Enterprise subscribers receive 48-hour guaranteed delivery on all CTD template requests. Starter subscribers receive 5-business-day delivery. Rush delivery (24-hour) is available on Enterprise plans.

Yes. All subscriptions are month-to-month with no long-term contracts or cancellation fees. You can cancel anytime through your Stripe billing portal. Your access continues until the end of your current billing period.

We offer a complimentary demo consultation where we can walk you through the Intelligence platform and discuss your specific regulatory needs. Book a free demo here.

Our technology transfer packages provide everything a manufacturer needs to produce a pharmaceutical product. Each package includes the complete master formula, validated analytical methods, ICH-compliant stability data, CTD/eCTD regulatory templates, detailed manufacturing protocols with batch records, and ongoing expert support.

We begin with a consultation to understand your requirements, then deliver the complete package within 2–21 business days depending on complexity.

We offer 75+ molecules across six therapeutic categories: Oncology (19 molecules), Diabetes & GLP-1 (8), Cardiovascular (21), Respiratory (8), Immunology (8), and Ophthalmics (11). Our portfolio includes high-demand molecules like Semaglutide, Tirzepatide, Pembrolizumab, Trastuzumab, and Aflibercept. Custom molecule development is also available on request.

Every package includes: master formula with complete formulation parameters, validated analytical methods (assay, impurities, dissolution, stability-indicating), ICH-compliant stability study data (accelerated and long-term), CTD/eCTD regulatory dossier templates, manufacturing protocols with scale-up procedures, equipment specifications, in-process controls, and batch records. You also receive direct advisory access to our formulation scientists.

Standard technology transfer packages are delivered within 2–21 business days through our secure portal, depending on the molecule complexity and scope of documentation required. Intelligence subscribers receive priority processing.

Yes. We provide regulatory guidance and CTD templates adapted for 30+ global markets including the US (FDA), EU (EMA), Canada (Health Canada), UK (MHRA), GCC, ASEAN, and many others. Our team understands the specific requirements and variations across different regulatory authorities.

We offer three types of paid advisory sessions: Quick Consult (30-minute focused session for specific regulatory questions), Regulatory Strategy (in-depth session for submission planning, market entry, and dossier review), and Technical Review (comprehensive review of formulation, analytical methods, or manufacturing processes). All sessions are conducted by our senior pharmaceutical scientists and regulatory specialists.

You can book directly through our website. We offer a free demo consultation or a 120-minute comprehensive review. Payment for paid sessions is processed securely through Stripe.

Yes. Pro subscribers receive priority expert advisory access included in their subscription. Enterprise subscribers receive dedicated account management with unlimited advisory hours. Starter subscribers can purchase advisory sessions separately at a discounted rate.

Burrard Pharmaceuticals is headquartered in Vancouver, British Columbia, Canada. We've been operating since 2005 and serve pharmaceutical companies, regulatory consultancies, and manufacturers in 30+ markets worldwide.

We work with generic pharmaceutical manufacturers seeking technology transfer packages, biotech companies developing biosimilars, regulatory consultancies needing CTD/eCTD templates, contract manufacturers looking for formulation know-how, and established pharma companies expanding into new markets or therapeutic areas.

The easiest way to get started is to book a free demo. We'll discuss your specific needs, recommend the right products and services, and outline a clear path forward. You can also email us at info@burrardpharma.com or call +1-778-279-1292.

Absolutely. All technology transfer documentation is delivered through our encrypted secure portal. We maintain strict confidentiality agreements with all clients, and our data handling practices comply with industry standards. Payment processing is handled securely by Stripe.